Page last updated: 2024-08-21

adamantane and Malaria, Vivax

adamantane has been researched along with Malaria, Vivax in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Abd-Rahman, AN; Ballard, E; Chalon, S; Collins, KA; Gobeau, N; Griffin, P; Marquart, L; McCarthy, JS; Möhrle, JJ1
Rosenthal, PJ1
Baker, M; Duparc, S; Imwong, M; Jittamala, P; Macintyre, F; Möhrle, JJ; Nosten, FH; Phyo, AP; Pukrittayakamee, S; White, NJ1

Trials

1 trial(s) available for adamantane and Malaria, Vivax

ArticleYear
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.
    The Lancet. Infectious diseases, 2016, Volume: 16, Issue:1

    Topics: Adamantane; Adolescent; Adult; Antimalarials; Cohort Studies; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Peroxides; Thailand; Young Adult

2016

Other Studies

2 other study(ies) available for adamantane and Malaria, Vivax

ArticleYear
Antimalarial Activity of Artefenomel Against Asexual Parasites and Transmissible Gametocytes During Experimental Blood-Stage Plasmodium vivax Infection.
    The Journal of infectious diseases, 2022, 03-15, Volume: 225, Issue:6

    Topics: Adamantane; Animals; Antimalarials; Culicidae; Folic Acid Antagonists; Humans; Malaria, Falciparum; Malaria, Vivax; Parasites; Peroxides; Plasmodium falciparum; Plasmodium vivax

2022
Artefenomel: a promising new antimalarial drug.
    The Lancet. Infectious diseases, 2016, Volume: 16, Issue:1

    Topics: Adamantane; Antimalarials; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Peroxides

2016